
Press Release|Articles|December 2, 2024
Camber Pharmaceuticals Introduces Lidocaine HCI Injection, USP, in Single- and Multi-Dose Vials
Listen
0:00 / 0:00
Key Takeaways
- Camber Pharmaceuticals introduces Lidocaine HCl Injection in single-dose and multi-dose vials with 1% and 2% concentrations.
- The product is available in various vial and pack sizes to meet diverse healthcare needs.
Featuring 1% and 2% concentrations, this versatile product is available in various vial and pack sizes to meet diverse healthcare needs.
Advertisement
Camber Pharmaceuticals is excited to introduce Lidocaine HCl Injection, USP, in Single-Dose and Multi-Dose Vials. Featuring 1% and 2% concentrations, this versatile product is available in various vial and pack sizes to meet diverse healthcare needs.
Click below to learn more:
- Single-Dose Vials:
https://www.camberpharma.com/products/lidocaine-sdv/ - Multi-Dose Vials:
https://www.camberpharma.com/products/lidocaine-mdv/
Camber Pharmaceuticals, a fully integrated pharmaceutical company, is dedicated to delivering high-quality generic medications that enhance lives through cost-effective healthcare solutions. As a subsidiary of Hetero, a global leader in active pharmaceutical ingredients (APIs) and finished dosage manufacturing based in Hyderabad, India, Camber leverages its expertise to ensure access to affordable, reliable pharmaceuticals for consumers worldwide.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
Hormone Therapy Use, Understanding, and Perceptions Have Positively Shifted From 2021 to 2025
4
New Data Show Elinzanetant Is a Safe, Well-Tolerated Non-Hormonal Therapy for Menopausal Vasomotor Symptoms
5













































































































































































































